Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 22 and 70 years old
- You have been diagnosed with Major Depressive Disorder (MDD) without psychosis, confirmed through a formal structured interview
- Your current episode of depression has lasted 2 years or longer and has not responded to treatment — specifically, you have tried at least 4 adequate treatments (including electroconvulsive therapy/ECT), at least 3 different types of medications, at least one add-on medication strategy, and psychotherapy
- You tried ECT but it either did not provide lasting relief (after 2 attempts to stop ECT it kept coming back) or you had to stop because the side effects were too difficult to tolerate
- Your depression symptoms score above 26 on a standard depression rating scale (called the MADRS) at both your screening and baseline appointments
- Your depression symptoms show some natural day-to-day variation, measured by a brief mood rating taken 3 times a day for 3 days (confirm with trial site)
- If you are already taking psychiatric medications, you have not changed them in the 4 weeks before joining and agree not to change them during the study
- You are willing and able to undergo a brain recording and stimulation procedure
- You are willing and able to come to multiple research visits and follow a research routine at home
- You are willing and able to give informed consent
- You can speak and read English
Who may not be able to join:
- You have been diagnosed with another major psychiatric condition such as a psychotic disorder, eating disorder, panic disorder, PTSD, bipolar disorder, OCD, a tic disorder, or another significant psychiatric disorder (note: generalized anxiety disorder alongside MDD may be acceptable — confirm with trial site)
- Your main diagnosis during your current depressive episode is generalized anxiety disorder rather than MDD
- You are currently having thoughts of suicide with a specific intent and plan
- You have been hospitalized for a suicide attempt in the past 2 years
- You have had problems with alcohol or substance misuse (other than caffeine) in the past 6 months
- You have a personality disorder that the study team believes could affect your safety or ability to follow the study requirements
- You have fibromyalgia or chronic fatigue syndrome
- You currently need to take narcotic (opioid) pain medications on an ongoing basis
- You have a history of traumatic brain injury, a neurological condition, or a developmental delay
- You have a history of seizures
- A recent brain MRI (within the past year) showed significant abnormalities
- You have previously had brain surgery to remove or destroy tissue, or you already have a deep brain stimulation device or another implanted brain stimulation device
- You have any implanted hardware in your body that is not compatible with MRI or with the study equipment
- You have serious medical conditions that would increase the risks of surgery — for example, severe diabetes, major organ failure, a history of bleeding stroke, need for blood-thinning medications (other than aspirin), active infection, a brain lesion, high pressure in the brain, a recent stroke, a brain aneurysm, retinal detachment, unstable heart disease, a weakened immune system, or cancer with a life expectancy of less than 5 years
- You are unable to safely stop blood-thinning or anti-clotting medications for surgery (your doctors would need to discuss this carefully — confirm with trial site)
- You have a blood clotting disorder, unless reviewed and cleared by a blood specialist
- You have allergies or known reactions to materials used in the NeuroPace RNS® device, such as titanium, silicone, or stainless steel
- You live alone with no one available to support you after your hospital stay
- You are unable to attend the required follow-up visits
- You are pregnant, planning to become pregnant, or currently breastfeeding
- You are unable to speak or read English
- You are unable to give informed consent
- You have significant memory or thinking difficulties or dementia (based on a standard cognitive test score below 25)
- You are likely to need ECT treatment during the course of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrew Krystal, MD, MS, University of California, San Francisco
Phone: 415-476-7439
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in MADRS score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.